| Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives G Kumar, S Mittal, K Sak, HS Tuli Life sciences 148, 313-328, 2016 | 131 | 2016 |
| Isothiocyanates: a class of bioactive metabolites with chemopreventive potential G Kumar, HS Tuli, S Mittal, JK Shandilya, A Tiwari, SS Sandhu Tumor Biology 36, 4005-4016, 2015 | 106 | 2015 |
| Molecular targets of gambogic acid in cancer: recent trends and advancements D Kashyap, R Mondal, HS Tuli, G Kumar, AK Sharma Tumor Biology 37, 12915-12925, 2016 | 98 | 2016 |
| Molecular aspects of metal oxide nanoparticle (MO-NPs) mediated pharmacological effects HS Tuli, D Kashyap, SK Bedi, P Kumar, G Kumar, SS Sandhu Life sciences 143, 71-79, 2015 | 78 | 2015 |
| Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements D Kashyap, G Kumar, A Sharma, K Sak, HS Tuli, TK Mukherjee Life Sciences 169, 27-36, 2017 | 65 | 2017 |
| Zinc oxide nanoparticles functionalized on hydrogel grafted silk fibroin fabrics as efficient composite dressing S Majumder, U Ranjan Dahiya, S Yadav, P Sharma, D Ghosh, GK Rao, ... Biomolecules 10 (5), 710, 2020 | 50 | 2020 |
| Apoptotic effect of cordycepin on A549 human lung cancer cell line HS Tuli, G Kumar, SS Sandhu, AK Sharma, D Kashyap Turkish Journal of Biology 39 (2), 306-311, 2015 | 39 | 2015 |
| Functional implications of vascular endothelium in regulation of endothelial nitric oxide synthesis to control blood pressure and cardiac functions G Kumar, SK Dey, S Kundu Life sciences 259, 118377, 2020 | 31 | 2020 |
| Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population S Gulati, A Yadav, N Kumar, G Kumar, N Aggarwal, R Gupta Environmental toxicology and pharmacology 37 (3), 1186-1193, 2014 | 13 | 2014 |
| Herbs and their bioactive ingredients in cardio-protection: Underlying molecular mechanisms and evidences from clinical studies G Kumar, SK Dey, S Kundu Phytomedicine 92, 153753, 2021 | 10 | 2021 |
| RhoBTB1 reverses established arterial stiffness in angiotensin II–induced hypertension by promoting actin depolymerization S Fang, J Wu, JJ Reho, KT Lu, DT Brozoski, G Kumar, AM Werthman, ... JCI insight 7 (9), 2022 | 8 | 2022 |
| Advances in mass spectrometric methods for detection of hemoglobin disorders P Dasauni, V Chhabra, G Kumar, S Kundu Analytical Biochemistry 629, 114314, 2021 | 8 | 2021 |
| Endothelial Cullin3 mutation impairs nitric oxide-mediated vasodilation and promotes salt-induced hypertension J Wu, S Fang, KT Lu, G Kumar, JJ Reho, DT Brozoski, AJ Otanwa, C Hu, ... Function 3 (3), zqac017, 2022 | 6 | 2022 |
| Synthesis, Characterization and in vitro anticancer activity of Co (II), Ni (II), Cu (II), and Zn (II) complexes with 4-[{3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-ylmethylene … K Singh, R Thakur, G Kumar Eur Chem Bull 5 (2), 46-53, 2016 | 5 | 2016 |
| Therapeutic enzymes as non-conventional targets in cardiovascular impairments: A comprehensive review G Kumar, M Saini, S Kundu Canadian Journal of Physiology and Pharmacology 100 (3), 197-209, 2022 | 4 | 2022 |
| Cytochrome B5 reductase 3 can be approached as a contemporary therapeutic target to restrain hypertension G Kumar, SK Dey, S Kundu The FASEB Journal 34 (S1), 1-1, 2020 | 4 | 2020 |
| Multiple putative methemoglobin reductases in C. reinhardtii may support enzymatic functions for its multiple hemoglobins M Shandilya, G Kumar, R Gomkale, S Singh, MA Khan, S Kateriya, ... International Journal of Biological Macromolecules 171, 465-479, 2021 | 2 | 2021 |
| Drug design strategies using non nucleoside reverse transcriptase inhibitors (NNRTI): current challenges and future perspectives R Sharma, G Kumar, P Saini, HS Tuli, S Sood J Biol Chem Sci 1, 1-12, 2014 | 2 | 2014 |
| Structure and function of RhoBTB1 required for substrate specificity and Cullin-3 ubiquitination G Kumar, S Fang, D Golosova, KT Lu, DT Brozoski, I Vazirabad, ... Function 4 (5), zqad034, 2023 | 1 | 2023 |
| Proteomic approach to explore the role of Rho-related BTB Domain Containing 1 (RhoBTB1)-Cullin-3 (CUL-3) pathway in identifying potential therapeutic candidates in cardioprotection G Kumar, I Vazirabad, D Golosova, KT Lu, D Brozoski, C Sigmund Physiology 38 (S1), 5730553, 2023 | | 2023 |
Hardeep Singh Tuli,MSc., PhD., Associate Professor, M.M. University, Mullana,Verified email at mmumullana.org
